Related Experiment Video
Updated: Sep 14, 2025
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
IMMUNE DYSREGULATION AND EPITHELIAL STRESS IN CELIAC DISEASE PROGRESSION: A FOCUS ON REFRACTORY CELIAC DISEASE
T Nikolaishvili1, C Farulava1, Sh Kepuladze2
11Davit Agmashenebeli University of Georgia, Tbilisi, Georgia.
Background:
Celiac disease (CD) is a chronic autoimmune disorder triggered by gluten, leading to immune-mediated injury in the small intestine. While many patients show improvement with a gluten-free diet (GFD), some progress to refractory celiac disease (RCD), a condition that is not responsive to GFD. The mechanisms behind RCD are poorly understood, particularly in distinguishing it from regular CD.
Aim Of Study:
This study aims to explore the immunohistochemical profiles of CD and RCD, with a focus on immune dysregulation and epithelial stress markers.
Material And Methods:
We conducted a retrospective analysis of 93 patients with CD, including those in Marsh stages 1, 2, 3a, and 3b, as well as RCD subtypes (Type I and Type II). Tissue samples were examined for the expression of CD3, CD8, CD103, FOXP3, Ki-67, MHC I, and MHC II, and the results were compared across the groups.
Results:
The study revealed progressive immune activation and epithelial stress as disease severity increased. FOXP3-positive regulatory T cells decreased significantly in RCD, especially in Type II, indicating a loss of immunoregulatory control. Elevated Ki67 indices were observed in the more severe stages, indicating active regeneration of epithelial cells. MHC II expression was upregulated in advanced stages, particularly in RCD, indicating enhanced antigen presentation.
Conclusion:
Our findings underscore the crucial role of immune dysregulation and epithelial stress in the transition from CD to RCD. A decrease in regulatory T cells (expressing FOXP3), increased cell proliferation (as indicated by Ki67), and heightened MHC II expression may be potential biomarkers for disease severity and progression. These results suggest that therapies targeting these pathways could enhance the management of RCD.
Related Concept Videos
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:30Other Disorders of Digestive System
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...